<p>(A) SKBR3 cells were lysed for Western blot analysis after pre-treatment with 40 μg/ml Herceptin for a period of 4 h, 2 d, or 10 d. Equal amounts of protein were loaded in each lane, and multiple parallel SDS-PAGE gels were run. Membranes were blotted with appropriate antibodies to assess the indicated proteins (shown here and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1002414#pbio.1002414.g002" target="_blank">Fig 2E</a>). Note that only one representative actin control is shown for this experiment. (B) SKBR3 cells were grown in 24-well plates and left to grow for at least 24 h before being treated with 40 μg/ml Herceptin for different durations, as illustrated. The viable cells were counted in a cell viab...
<p>(A) RT-PCR showed BMP9 inhibited HER2 mRNA expression in SK-BR-3 cells. (B) Western blot assay de...
<p>(A) Representative images of Western blots evaluating the effects of the single or combined inhib...
BACKGROUND: Elucidating the molecular mechanisms by which tumors become resistant to Herceptin is cr...
<p>(A) SKBR3 cells were treated with 10 μM ADAM17 inhibitor (inh), 10 μM ADAM10/17 inhibitor, 10 μM ...
<p>(<b>A</b>) Her-2 amplified SK-BR-3 cells were transfected with nonspecific siRNA or Her-2 siRNA. ...
<p>(A) Flow cytometric analysis of HER2 levels in SK-BR-3 cells treated with the indicated concentra...
Herceptin (trastuzumab) is used in patients with breast cancer who have HER2 (ErbB2)-positive tumour...
Herceptin, an anti-neoplastic humanized monoclonal antibody (Herceptin®, Roche, CH), has been shown ...
<p>Cell viability after treatment with various concentrations of elisidepsin for 72 h was determined...
HER2 overexpression occurs in approximately 15-20% of all breast cancers and is associated with poor...
<p>A) PMCA2 levels in control versus HER2KD-SKBR3 cells as assessed by immunoblot. B) Intracellular ...
<p>a) MDA-MB-453 cells were incubated in serum-free medium for 16 hrs followed by treatment with her...
<p>Experimental data (open bars) and model predictions (shaded bars) for the HER3 phosphorylation le...
<p>(<b>A</b>) Immunoblot of 1AT, HRD1, BiP and Hsp90 protein expression in cell lysates following si...
HER-2 is a cell membrane protein that belongs to the ErbB family of receptor tyrosine kinases (HER-1...
<p>(A) RT-PCR showed BMP9 inhibited HER2 mRNA expression in SK-BR-3 cells. (B) Western blot assay de...
<p>(A) Representative images of Western blots evaluating the effects of the single or combined inhib...
BACKGROUND: Elucidating the molecular mechanisms by which tumors become resistant to Herceptin is cr...
<p>(A) SKBR3 cells were treated with 10 μM ADAM17 inhibitor (inh), 10 μM ADAM10/17 inhibitor, 10 μM ...
<p>(<b>A</b>) Her-2 amplified SK-BR-3 cells were transfected with nonspecific siRNA or Her-2 siRNA. ...
<p>(A) Flow cytometric analysis of HER2 levels in SK-BR-3 cells treated with the indicated concentra...
Herceptin (trastuzumab) is used in patients with breast cancer who have HER2 (ErbB2)-positive tumour...
Herceptin, an anti-neoplastic humanized monoclonal antibody (Herceptin®, Roche, CH), has been shown ...
<p>Cell viability after treatment with various concentrations of elisidepsin for 72 h was determined...
HER2 overexpression occurs in approximately 15-20% of all breast cancers and is associated with poor...
<p>A) PMCA2 levels in control versus HER2KD-SKBR3 cells as assessed by immunoblot. B) Intracellular ...
<p>a) MDA-MB-453 cells were incubated in serum-free medium for 16 hrs followed by treatment with her...
<p>Experimental data (open bars) and model predictions (shaded bars) for the HER3 phosphorylation le...
<p>(<b>A</b>) Immunoblot of 1AT, HRD1, BiP and Hsp90 protein expression in cell lysates following si...
HER-2 is a cell membrane protein that belongs to the ErbB family of receptor tyrosine kinases (HER-1...
<p>(A) RT-PCR showed BMP9 inhibited HER2 mRNA expression in SK-BR-3 cells. (B) Western blot assay de...
<p>(A) Representative images of Western blots evaluating the effects of the single or combined inhib...
BACKGROUND: Elucidating the molecular mechanisms by which tumors become resistant to Herceptin is cr...